Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 5/20 | 0.69 |
| ▸ | FNTB | P49356 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | SQLE | Q14534 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15315193 | 1.00 | FNTA (0.69) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL1105228 | 1.00 | FNTA (0.69) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL11619480 | 1.00 | FNTA (0.69) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL8758581 | 1.00 | FNTA (0.69) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL11619483 | 1.00 | FNTA (0.69) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL806737 | 0.98 | FNTA (0.66) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL1409916 | 0.98 | FNTA (0.66) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL5361163 | 0.98 | FNTA (0.66) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL28603272 | 0.94 | FNTA (0.63) | FNTAFNTBKMT2AMAPTMEN1 | |
| SCHEMBL1395165 | 0.87 | FNTA (0.72) | FNTAFNTBKMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111741943-B | Method for isomerising 3- (Z) -unsaturated carboxylic acids into 3- (E) -isomers | 巴斯夫欧洲公司 | 2024-07-02 | — | — | CN | claimed |
| CN-114989000-B | Process for preparing unsaturated carboxylic acids by carbonylation of allyl alcohol and its acylated products | 巴斯夫欧洲公司 | 2024-05-10 | — | — | CN | claimed |
| EP-2922813-B1 | HYDROCARBONYLATION OR METHOXYCARBONYLATION OF 1,3-DIENE DERIVATIVES WITH PALLADIUM COMPLEX | FIRMENICH & CIE (CH) | 2016-10-12 | — | — | EP | claimed |
| US-9376365-B2 | Hydrocarbonylation or methoxycarbonylation of 1,3-diene derivatives with palladium complex | FIRMENICH SA (CH) | 2016-06-28 | — | — | US | claimed |
| US-20150299085-A1 | HYDROCARBONYLATION OR METHOXYCARBONYLATION OF 1,3-DIENE DERIVATIVES WITH PALLADIUM COMPLEX | FIRMENICH SA (CH) | 2015-10-22 | — | — | US | claimed |
| EP-2922813-A1 | HYDROCARBONYLATION OR METHOXYCARBONYLATION OF 1,3-DIENE DERIVATIVES WITH PALLADIUM COMPLEX | Firmenich SA (CH) | 2015-09-30 | — | — | EP | claimed |
| WO-2014079691-A1 | HYDROCARBONYLATION OR METHOXYCARBONYLATION OF 1,3-DIENE DERIVATIVES WITH PALLADIUM COMPLEX | FIRMENICH SA (CH) | 2014-05-30 | — | — | WO | claimed |
| US-4520029-A | ANTIINFLAMMATORY AND ANTIULCER AGENTS | KOTOBUKI SEIYAKU CO., LTD. (JP) | 1985-05-28 | — | — | US | claimed |
| JP-2258773-A | — | — | None | — | — | JP | disclosed |
| JP-60123483-A | — | — | None | — | — | JP | disclosed |
| US-12172956-B2 | Method for the isomerization of a 3-(Z)-unsaturated carboxylic acid to the 3-(E)-isomer | BASF SE (DE) | 2024-12-24 | — | — | US | disclosed |
| CN-111741943-B | Method for isomerising 3- (Z) -unsaturated carboxylic acids into 3- (E) -isomers | 巴斯夫欧洲公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-114989000-B | Process for preparing unsaturated carboxylic acids by carbonylation of allyl alcohol and its acylated products | 巴斯夫欧洲公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-110325646-B | Process for preparing (3E, 7E) -Gao Fani acid or (3E, 7E) -Gao Fani acid esters | 巴斯夫欧洲公司 | 2024-02-09 | — | — | CN | disclosed |
| US-4520029-A | ANTIINFLAMMATORY AND ANTIULCER AGENTS | KOTOBUKI SEIYAKU CO., LTD. (JP) | 1985-05-28 | — | — | US | disclosed |
| US-4520029-A | ANTIINFLAMMATORY AND ANTIULCER AGENTS | KOTOBUKI SEIYAKU CO., LTD. (JP) | 1985-05-28 | — | — | US | disclosed |
| US-4503240-A | Process for preparing 8,12-epoxy-13,14,15,16-tetranorlabdane | Consortium F/u/ r Elektrochemische Industrie GmbH (DE) | 1985-03-05 | — | — | US | disclosed |
| US-4209529-A | ANTIULCER AGENTS | KOTOBUKI SEIYAKU COMPANY LIMITED (JP) | 1980-06-24 | — | — | US | disclosed |
| US-4209529-A | ANTIULCER AGENTS | KOTOBUKI SEIYAKU COMPANY LIMITED (JP) | 1980-06-24 | — | — | US | disclosed |
| US-4116955-A | META-CYCLOPHANE AND A TRANS-TERPENOID, SEPARATION OF ISOMERS | TEIJIN LIMITED (JP) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299085-A1 | HYDROCARBONYLATION OR METHOXYCARBONYLATION OF 1,3-DIENE DERIVATIVES WITH PALLADIUM COMPLEX | PHOSPHO1, PDCD1LG2, PDK2 | FNTA 1235/4885FNTB 928/4885KMT2A 555/4885 |
| US-12172956-B2 | Method for the isomerization of a 3-(Z)-unsaturated carboxylic acid to the 3-(E)-isomer | HCAR2, HCAR1, AKR1C3 | FNTA 1530/4885FNTB 2615/4885KMT2A 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.